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Abstract 
Polyunsaturated fatty acids (PUFA) including the long chain omega-3 PUFA (LC n-3 PUFA) are 
important for health.  The aim was to assess if the anti-Cancer Council of Victoria dietary 
questionnaire (ACC DQ) accurately determines PUFA intakes by comparison to the recently 
validated electronic PUFA food frequency questionnaire (FFQ).  Forty-one study volunteers were 
recruited from the local Illawarra region of New South Wales, Australia.  The method of triads was 
used to determine validity coefficients by comparing the ACC DQ intakes against a 3 day weighed 
food record (FR) and appropriate blood biomarkers (erythrocyte and plasma fatty acids).  These 
validity coefficients were subsequently compared to previously published validity coefficients from 
the PUFA FFQ.  Using erythrocytes as the biomarker, the electronic PUFA FFQ had much higher 
validity coefficients compared to the ACC DQ for EPA (0.92 vs 0.19), DHA (0.69 vs 0.26) and 
total LC n-3 PUFA (0.78 vs 0.23), respectively, whereas omega-6 (n-6) PUFA were comparable.  
Using plasma as the biomarker, the electronic PUFA FFQ had much higher validity coefficients 
compared to the ACC DQ, for alpha-linolenic acid (ALA) (0.96 vs 0.49), EPA (0.87 vs 0.19), DHA 
(0.64 vs 0.24) and total LC n-3 PUFA (0.73 vs 0.21), respectively, whereas n-6 PUFA were 
comparable.  In conclusion, the validated electronic PUFA FFQ is better suited to determine n-3 
PUFA intakes than the ACC DQ. 
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Introduction 
 
Polyunsaturated fatty acids (PUFA) comprise of omega-6 (n-6) and omega-3 (n-3) PUFA.  N-6 
PUFA linoleic acid (LA) is an essential fatty acid which can be readily converted to arachidonic 
acid (AA) [1] and both of these fatty acids can be incorporated into cells in the body, such as 
erythrocytes [2].  N-3 PUFA alpha-linolenic acid (ALA) is the other essential fatty acid which can 
be converted to the long chain (LC) n-3 PUFA, EPA, docosapentaenoic acid (DPA) and DHA, 
although this conversion appears to be minimal [1]. 
PUFA, especially LC n-3 PUFA are essential for growth and development [3] and numerous 
health benefits have been attributed to these LC n-3 PUFA [4-7].  Hence there is a need to assess 
dietary PUFA accurately and quickly.  Food frequency questionnaires (FFQs) are especially useful 
in epidemiology where large samples sizes are used.  A great number of researchers use the anti-
Cancer Council of Victoria dietary questionnaire (ACC DQ) to determine energy, macronutrient 
and micronutrients intakes, including individual PUFA intakes.  However, it is known that tailor-
made FFQs are more accurate at determining intakes of specific nutrients, than generic FFQs [8,9].   
In terms of assessing LC n-3 PUFA intakes, Sullivan and colleagues developed and validated a 
specific LC n-3 PUFA FFQ [10,11].  That original questionnaire only contained questions about the 
main foods that contribute to the LC n-3 PUFA intakes (e.g. fish/seafood, meat and eggs).  Since 
then, that LC n-3 PUFA FFQ has been extended to include questions that capture intakes of other 
PUFA, namely ALA, LA and AA.  Furthermore, this PUFA FFQ has been converted to an 
electronic format allowing automatic calculation of PUFA intakes and has recently been validated 
[2]. 
Nevertheless, researchers have used generic dietary questionnaires like the ACC DQ to assess 
PUFA intakes including the LC n-3 PUFA.  Therefore the aim was to compare the electronic PUFA 
FFQ with the ACC DQ to determine its suitability to determine PUFA intakes accurately. 
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Methods 
Ethics approval 
This study received ethics approval from the University of Wollongong Human Research Ethics 
Committee and written informed consent was obtained from all study volunteers.  The study was 
conducted in accordance with the guidelines laid down in the Declaration of Helsinki. 
 
Study power and recruitment of study volunteers 
A power calculation determined that at least 40 study volunteers would be sufficient to detect an 
effect size of 0.65, with 99% power at a significance level of 0.05, assuming a correlation between 
methods of 0.6 [12].  
Forty eight adults (23 males and 25 females) were recruited from recreation centres, medical 
practices and clubs in the Illawarra region of New South Wales, Australia.  Study volunteers were 
included in the study if they were generally healthy and had not changed their usual diet in any way 
for the previous 3 months. 
 
Clinic visits 
Study volunteers attended a single clinic visit at the University of Wollongong.  A fasted blood 
sample (9ml) was taken into EDTA tubes for fatty acid analysis; weight was measured using a 
digital scale; height was measured using a free-standing stadiometer and the study volunteers were 
asked to complete dietary questionnaires.  At the end of the clinic visit, the study volunteers were 
provided with the necessary equipment to record a 3 day weighed FR (see below). 
 
Fatty Acid Analysis 
The fasted blood sample was subjected to centrifugation at 3,500rpm, 4◦C for 10 minutes to separate 
plasma and the erythrocytes, which were subsequently stored at -80◦C until analysed for fatty acids. 
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Both erythrocyte (400µl of packed erythrocytes) and plasma (200µl) fatty acids were extracted 
using the Folch method with minor modifications [13] and esterified according to Lepage and Roy 
[14].  A detailed description of the fatty acid analysis is described in Swierk et al [2].   
 
The anti-Cancer Council of Australia Dietary Questionnaire  
The study volunteers were asked to complete the ACC DQ.  This questionnaire is designed to 
capture a person’s whole diet.  There were questions relating to 1) foods such as breads and cereals, 
milk, cheese, meat, fish, egg, sugar, sweets, snacks, fruit and vegetable consumption; 2) portion 
sizes (including pictures of plates containing foods) and 3) alcohol consumption.  The potential 
responses to the questions were never, less than once per month, 1 to 3 times per month, 1 time per 
week, 2 times per week, 3 to 4 times per week, 5 to 6 times per week, 1 time per day, 2 times per 
day, 3 or more times per day.   
The completed questionnaires were scanned by the anti-Cancer Council of Victoria and the data 
provided was: total energy (fat, protein, carbohydrate, alcohol), total fat (saturated, 
monounsaturated, polyunsaturated, including individual fatty acids), total protein (animal and 
plant), total carbohydrate (starch and simple sugars), fibre, vitamins, minerals and trace elements. 
 
The electronic PUFA Food Frequency Questionnaire 
The recently validated [2] electronic PUFA FFQ consists of 38 questions regarding the usual dietary 
habits related to PUFA intake.  The questions are specific to food items that are sources of PUFA, 
such as fish, meat, eggs, nuts and oils.  Questions relating to fish oil capsule consumption were also 
included, as well as n-3 PUFA enriched foods such as bread, eggs and milk.  The frequency of 
consumption was similar to the ACC DQ ranging from never to intake per month, per week or per 
day.  For the portion sizes of meat, chicken and fish, a picture o a standard dinner plate was used, 
with diagrams of different sized portions, allowing the study volunteer to visualise the amount 
consumed.  The electronic format of the PUFA FFQ allows automatic calculation of PUFA intakes 
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(g/day) per food grouping.  The Australian RMIT Fatty Acid Database [15] was the database used 
in this automatic calculation.  The PUFA intakes data (g/day) generated were LA, AA, ALA, EPA, 
DPA, DHA and total LC n-3 PUFA (EPA + DPA + DHA) and total PUFA. 
 
Weighed Food Record 
The 3 day weighed FR was used as the reference method as it is regarded as the ‘gold standard’ in 
relation to other dietary intake assessments as it does not rely on memory [16] Three day weighed 
FR was chosen over a 7 day weighed FR to reduce participant burden.  Previously we have shown 
that a 3 day weighed FR was long enough o capture usual fatty acid intakes, as a repeat 3 day 
weighed FR was not significantly different from the first 3 day weighed FR [11].  The 3 day 
weighed FR in this current study covered two week days and one weekend day, and were not 
necessarily consecutive days.  At the end of the clinic visit, the study volunteers were shown how to 
record their food and beverage intake for 3 days.  They were provided with a set of kitchen scales, 
measuring cups, spoons and a FR diary with written instructions.  They were also asked to retain 
food labels where possible, include brand names and pay particular attention to the fats and oils 
they consumed.  For meals outside the home, they were asked to estimate items and portion sizes as 
best they could and to return their FR within two weeks of their clinic visit. 
 
The Foodworks nutrient analysis software package [17] was used to enter the FR.  The Australian 
Standard Database in the Foodworks software, which was based on the AUSNUT database, was 
used to determine the total daily energy intakes (EI) for the study volunteers.  Their basal metabolic 
rate (BMR) was calculated by the software, using the Schofield equation [18].  
To determine total PUFA and individual PUFA intakes, the aforementioned Australian RMIT Fatty 
Acid Database [15] in the Foodworks software was used.  This RMIT fatty acid database contains 
only analytical data of foods and there were no estimated or calculated data of foods, which is a 
common feature of various databases.   
7 
 
 
Determination of under-reporters 
The Goldberg cut-off limits used the principle of energy physiology to determine under-reporting 
study volunteers from the FR [19].  The ratio between energy intake and basal metabolic rate 
(EI:BMR) was determined and study volunteers with an EI:BMR of 1.06 or less were excluded 
from statistical analysis.  
 
Statistical analysis 
Wilcoxon/Kruskall Wallis Tests (Rank-Sums) were used to determine significant difference in 
intakes between the PUFA FFQ, the FR and the ACC DQ. 
The method of triads is a statistical model which uses a triangular comparison between a 
questionnaire (in this case the ACC DQ), reference method (in this case the FR) and a biomarker (in 
this case 2 biomarkers were used: erythrocyte fatty acids and plasma fatty acids) [20, 21]. The 
method of triads was used to determine the validity coefficients () between the dietary assessment 
(the ACC DQ) and the true intake (T), by comparison with at least two other measurements (i.e. FR 
and the biomarker).  A detailed description of the method of triads analysis is described in Swierk et 
al [2].  The closer the validity coefficient is to 1, the closer the intake estimated by the dietary 
assessment is to the true intake (T).  Two separate analyses were performed, with the first set of 
analysis using erythrocytes as the biomarker, and the second analysis using plasma as the 
biomarker.  
The validity coefficients of the current study were compared to the previously published PUFA 
FFQ to determine which dietary questionnaire is superior in terms of assessing the true intakes (T). 
Statistical significance was set at P<0.05 for all analyses. 
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Results 
Forty-eight study volunteers were eligible for the study.  Seven study volunteers were excluded due 
to under-reporting in the FR, as their EI:BMR was less than 1.06 [19].  The characteristics of the 
remaining 41 study volunteers are shown in Table 1.  On average the study volunteers were middle 
age, overweight and with normal blood pressures.  There were no differences in characteristics 
between the males and females. 
 
Dietary PUFA intakes comparison 
There were no differences between intakes of LA, ALA, EPA and DHA between the ACC DQ, the 
electronic PUFA FFQ and the FR (Figure 1A and 1B).  There were no differences between total 
PUFA intakes between the ACC DQ, the electronic PUFA FFQ and the FR (data not shown).  
However the PUFA FFQ estimate of DPA and AA intakes were significantly higher (P < 0.001) 
than the FR, whilst the ACC DQ estimate of AA was significantly lower (P < 0.001) than the FR 
(Figure 1B).   
 
Assessment of True Dietary Intake using the method of triads analysis and comparison between the 
electronic PUFA FFQ and the ACC DQ 
The validity coefficients calculated using the methods of triads are shown in Table 2 (erythrocytes 
as the biomarker) and Table 3 (plasma as the biomarker).  Comparison of the validity coefficients 
between the ACC DQ and the PUFA FFQ [2] for true dietary intake (T) are shown in Figure 2.  The 
validity coefficients of the n-6 PUFA were comparable between ACC DQ and PUFA FFQ; whilst 
the validity coefficients of EPA, DHA, LC n-3 PUFA and ALA were 80%, 60%, 70% and 50% 
lower respectively, when using the ACC DQ compared to the electronic PUFA FFQ (Figure 2). 
  
9 
 
Discussion 
This study highlights the importance of utilising a tailor made FFQ when assessing the intakes of 
specific nutrients in the diet like omega-3 PUFA as opposed to assessing the whole diet.  The ACC 
DQ was designed to assess the whole diet rather than to specifically to determine n-3 PUFA intakes, 
whereas the recently validated electronic PUFA questionnaire was specifically designed to assess 
PUFA intakes [2].   
The essential PUFA LA and ALA intakes (Figure 1A) are comparable across all three methods 
of dietary intake (FR, PUFA FFQ and ACC DQ).  These actual intakes are slightly higher than 
McNaughton et al. [22] but comparable to other Australian published intakes [23-25].  EPA and 
DHA intakes (Figure 1B) are also comparable across all three methods of dietary intake capture and 
are also comparable to other Australian published intakes [22, 24, 25].  However, AA and DPA 
differed between the three methods. 
Intakes of AA and DPA as measured by the PUFA FFQ were significantly higher than when 
assessed by ACC DQ and the FR (Figure 1B).  Meat is the main dietary source of both AA and 
DPA and accounts for 73% of DPA intake [26].  The PUFA FFQ has detailed questions regarding 
dietary intake of various meats and this could partially explain why these intakes were higher than 
the other two dietary methods (FR and ACC DQ).  One could speculate that the PUFA FFQ 
assessment of AA and DPA intakes is more accurate than the ACC DQ, as the estimates of AA 
(162mg) and DPA (90mg) are comparable to previously estimated intakes of 153mg for AA and 
71mg for DPA from the 1995 Australian National Nutrition Survey (NNS) [25].  The estimates 
determined by Howe et al. [26] used analytical data on meat [27].  The previously reported 
estimates of AA (52mg) and DPA (26mg) from the 1995 NNS [24] were much lower than Howe et 
al. [26] because the analytical data on meat was not yet available and hence these fatty acid intakes 
were underestimated [24].  Hence it is conceivable that the ACC DQ and the FR underestimated 
intakes of AA and DPA, whilst the PUFA FFQ accurately assessed their intakes. 
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Many biomarkers are not reflective of true absolute intakes due to the effects of absorption, 
tissue uptake, metabolism and excretion [28].  For example, it is well known that dietary LA can be 
converted to AA [1]  and both these fatty acids are incorporated into cell membranes [29].  Even 
though dietary intake of LA is approximately 60 fold higher than AA (9.9g vs 0.16g), there is 
preferential uptake of AA compared to LA (1.6 fold higher) in erythrocyte membranes [29].  
Certain fatty acids that are metabolised to other fatty acids prior to incorporation into tissues are 
therefore not good biomarkers.  The Swierk et al. [2] study showed that there were poor correlations 
between LA and AA and their respective biomarkers, as dietary LA is converted to AA [1, 30].  
Furthermore, DPA either resulted in a Heywood case, where the method of triads was violated, or 
there was a negative correlation.  Other studies have also seen poor correlations between DPA 
intake and biomarkers for these same reasons [10, 11, 22, 31].  DPA in erythrocytes are 
approximately 2 to 2.5% of total fatty acids, irrespective of dietary intakes of DPA [10].  These 
poor correlations could be partially explained by the metabolism of DPA.  It is well documented 
that EPA can be converted to DPA and that DPA can be retro-converted from DHA [1].  DPA can 
also be converted to DHA, although this conversion is minimal and females are able to convert 
more DPA to DHA [1].  The likely explanation for this is oestrogen, as women taking oral 
contraception are able to convert more DPA to DHA than women not taking oral contraception [1]. 
Other dietary fatty acids like EPA and DHA correlate well with biomarkers such as plasma and 
erythrocyte levels [10].  Plasma fatty acids are used as a biomarker and reflect recent intakes, more 
so than erythrocytes which reflect more long-term intakes [32].  Erythrocyte fatty acids are 
indicative of other tissue levels of fatty acids as the levels of fatty acids in heart [23], brain [34], and 
cheek cells [35] are comparable to erythrocyte levels.  In this study both erythrocytes and plasma 
were used as biomarkers in the method of triads analysis.  The ACC DQ had similar validity 
coefficients to the PUFA FFQ for LA, AA and total n-6 PUFA using erythrocytes as the biomarker 
(Figure 2A).  Likewise, the ACC DQ had similar validity coefficients to the PUFA FFQ for LA and 
total n-6 PUFA using plasma as the biomarker (Figure 2B).  However, the PUFA FFQ had much 
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higher validity coefficients for the n-3 PUFA with both erythrocytes and plasma (Figure 2).  The 
higher validity coefficients from the electronic PUFA FFQ compared to the ACC DQ (using 
erythrocytes as a biomarker) for EPA (0.92 vs 0.19), DHA (0.69 vs 0.26) and total LC n-3 PUFA 
(0.78 vs 0.23), respectively, clearly demonstrate the benefits of tailor made FFQ.   
The PUFA FFQ validity coefficients using erythrocytes as the biomarker (Figure 2A) were much 
higher (ranging from 0.69-0.92) than the ACC DQ (ranging from 0.19-0.26).  Likewise, the PUFA 
FFQ validity coefficients using plasma as the biomarker (Figure 2B) were also much higher 
(ranging from 0.64-0.96) than the ACC DQ (0.19-0.49).  The only other published study which 
utilised the method of triads to determine validity coefficients was the assessment of the Nambour 
FFQ [22].  This study utilised plasma phospholipid fatty acids in non-fasted samples and the 
validity coefficients for EPA, DHA and total LC n-3 PUFA were 0.62, 0.62 and 0.63 respectively 
[22].  The PUFA FFQ validity coefficients for DHA (0.64) were comparable but EPA (0.87) and 
total LC n-3 PUFA (0.73) were higher than McNaughton et al. [22].  As the Nambour FFQ was not 
a tailor-made questionnaire, it is conceivable that a FFQ designed for a specific purpose is an 
improved dietary assessment tool compared to a general FFQ.  Certainly other FFQs designed to 
capture intakes of specific nutrients are able to better estimate intakes of nutrients compared with 
generic FFQ that assess total dietary intake.  Tailor-made FFQs are usually shorter than those used 
to assess whole diets [28] and increased food items in FFQs affect the accuracy of the responses 
[36].  A specific 40-item FFQ to assess the intake of soy isoflavone, genistein and daidzein, 
compared to an extensive 122-item FFQ showed very good correlations of 0.83 and 0.82 
respectively [8].  Likewise a specific FFQ to assess calcium intakes compared to a 14 day weighed 
FR also showed an excellent correlation of 0.9 [9] compared to generic FFQs that were used to 
assess calcium intakes which had correlations of 0.36 [37] and 0.35 [38].  Therefore the tailor made 
FFQs, together with the PUFA FFQ suggest that nutrient specific FFQs are more accurate than 
generic dietary assessments.  The comparison of the PUFA FFQ to the ACC DQ clearly shows that 
a tailor-made questionnaire is superior to a general questionnaire in terms of assessing PUFA 
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intakes accurately, especially the n-3 PUFA. FFQs that assess the whole diet cannot be expected to 
accurately estimate specific nutrients such as fatty acids.   
In conclusion, the electronic validated PUFA FFQ is better suited to determine n-3 PUFA intakes 
than the ACC DQ. 
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Figures 
Figure 1A   
Comparison of linoleic acid (LA) and alpha-linolenic acid (ALA) median intakes (g/day) as measured by 3 day weighed 
food record (FR, ■), the polyunsaturated fatty acid food frequency questionnaire (PUFA FFQ, □) and the anti-Cancer 
Council of Victoria dietary questionnaire (ACC DQ, ▓).  a, b, c   Significant differences occur when the letters differ 
between the 3 dietary intakes, P <0.001  
 
Figure 1B   
Comparison of arachidonic acid (AA), EPA, docosapenaenoic acid (DPA) and DHA median intakes (mg/day) as 
measured by 3 day weighed food record (FR, ■), the polyunsaturated fatty acid food frequency questionnaire (PUFA 
FFQ, □) and the anti-Cancer Council of Victoria dietary questionnaire (ACC DQ, ▓). a, b, c   Significant differences 
occur when the letters differ between the 3 dietary intakes, P <0.001  
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Figure 2A   
Comparison of the validity coefficients between the PUFA FFQ (■) and the ACC DQ (□) for true dietary intake (T) 
using erythrocytes as the biomarker. 
 
Figure 2B   
Comparison of the validity coefficients between the PUFA FFQ (■) and the ACC DQ (□) for true dietary intake (T) 
using plasma as the biomarker. 
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Tables 
 
Table 1  Characteristics of the study volunteers (n=41) 
 Males (n=20) Females (n=21) 
Age (years) 43 + 20 (20-79) 41 + 16 (19-63) 
BMI (kg/m2) 27 + 5 (16-38) 27 + 6 (20-40) 
Systolic Blood Pressure 
(mmHg) 
123 + 15 (97-151) 113 + 15 (89-146) 
Diastolic Blood Pressure 
(mmHg) 
71 + 8 (54-83) 68 + 8 (54-83) 
Values are mean + SD (range) 
BMI = body mass index 
 
Table 2: Mean validity coefficients (ρ) and 95% confidence intervals (CI) estimated by the method of triads for the ACC DQ, FR and 
erythrocytes (n = 41). 
Fatty Acid 
Erythrocytes as biomarker 
 Validity Coefficient 
ACC DQ vs. T     
95% CI 
Validity Coefficient 
FR vs. T 
95% CI 
Validity Coefficient 
Biomarker vs. T 
95% CI 
Omega-3 PUFA       
     EPA 0.19 (0.04, 0.58) 1.00* (0.48, 1.00) 0.94 (0.60, 1.00) 
     DPA 0.74 (0.16, 0.95) 0.59 (0.06, 0.96) 0.67 (0.07, 0.94) 
     DHA 0.26 (0.05, 0.66) 0.86 (0.40, 0.98) 0.87 (0.47, 0.98) 
     Total LC n-3 PUFA 0.23 (0.04, 0.65) 1.00* (0.38, 0.99) 0.85 (0.46, 0.98) 
Omega-6 PUFA       
     LA  0.37 (0.13, 0.73) 0.83 (0.37, 0.98) 0.61 (0.30, 0.94) 
     AA 0.82 (0.15, 0.97) 0.86 (0.14, 0.97) 0.25 (0.05, 0.72) 
     Total n-6 PUFA 0.42 (0.14, 0.85) 0.85 (0.24, 0.98) 0.48 (0.16, 0.90) 
Total PUFA 0.39 (0.06, 0.85) 1.00* (0.18, 0.98) 0.37 (0.08, 0.86) 
 
* Validity coefficients > 1 (Heywood cases) were set to 1.00. 
  
Table 3: Mean validity coefficients (ρ) and 95% confidence intervals (CI) estimated by the method of triads for the ACC DQ, FR and plasma (n 
= 41). 
Fatty Acid 
Plasma as biomarker 
 Validity Coefficient 
ACC DQ vs. T     
95% CI 
Validity Coefficient 
FR vs. T 
95% CI 
Validity Coefficient 
Biomarker vs. T 
95% CI 
Omega-3 PUFA       
     ALA 0.49 (0.07, 0.89) 0.60 (0.10, 0.94) 0.41 (0.06, 0.88) 
     EPA 0.19 (0.04, 0.53) 1.00* (0.57, 1.00) 0.93 (0.63, 0.99) 
     DPA 0.40 (0.08, 0.89) 0.84 (0.16, 0.98) 0.58 (0.13, 0.91) 
     DHA 0.24 (0.04, 0.62) 0.86 (0.46, 0.99) 0.86 (0.49, 0.99) 
     Total LC n-3 PUFA 0.21 (0.04, 0.59) 0.99 (0.47, 1.00) 0.89 (0.54, 0.99) 
     Total n-3 PUFA 0.28 (0.07, 0.70) 0.97 (0.19, 0.99) 0.82 (0.40, 0.97) 
Omega-6 PUFA       
     LA  0.61 (0.12, 0.94) 0.72 (0.16, 0.95) 0.25 (0.04, 0.69) 
     AA 0.45 (0.12, 0.92) 1.00* (0.33, 0.99) 0.21 (0.04, 0.53) 
     Total n-6 PUFA 0.64 (0.12, 0.95) 0.70 (0.15, 0.95) 0.22 (0.04, 0.65) 
Total PUFA 0.61 (0.12, 0.95) 0.72 (0.13, 0.96) 0.25 (0.04, 0.70) 
* Validity coefficients > 1 (Heywood cases) were set to 1.00. 
